Crossref
The low hanging fruit of anti‐inflammatory reliever therapy
Respirology · 2024
DOI: 10.1111/resp.14653 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respirology, 2024. Verfasst von Richard Beasley. Beteiligte Einrichtung: Medical Research Institute of New Zealand, Wellington, New Zealand. Hauptthemen laut MEDLINE: Budesonide, Anti-Asthmatic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
BudesonideAnti-Asthmatic AgentsHumansBronchodilator AgentsAnti-Inflammatory AgentsFormoterol FumarateAdministration, InhalationEthanolaminesAdrenal Cortex HormonesDrug Combinations
Stichwörter der Autor:innen
anti-inflammatory reliever therapyasthmasevere exacerbations
Substanzen
BudesonideBronchodilator AgentsAnti-Inflammatory AgentsFormoterol FumarateAnti-Asthmatic AgentsEthanolaminesAdrenal Cortex HormonesDrug Combinations
Autor:innen und Institutionen
- Medical Research Institute of New Zealand, Wellington, New Zealand.
ORCID-Profile: Richard Beasley
Zitieren
APA
Beasley, R. (2024). The low hanging fruit of anti‐inflammatory reliever therapy. Respirology. https://doi.org/10.1111/resp.14653
Vancouver
Beasley R. The low hanging fruit of anti‐inflammatory reliever therapy. Respirology. 2024. doi:10.1111/resp.14653
BibTeX
@article{Beasley2024,
author = {Beasley, Richard},
title = {The low hanging fruit of anti‐inflammatory reliever therapy},
journal = {Respirology},
year = {2024},
doi = {10.1111/resp.14653}
}
EUVIMED